New drug safety study targets kidney patients

NCT ID NCT07217886

Recruiting now Knowledge-focused Sponsor: Shionogi Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times

Summary

This study looks at how the body handles a new drug called S-892216 in people with mild, moderate, or severe kidney problems, including those on dialysis, compared to people with healthy kidneys. About 40 adults will take a single dose of the drug, and researchers will measure drug levels in the blood and dialysis fluid. The goal is to understand how kidney function affects the drug's safety and processing, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alliance for Multispecialty Research (AMR)-Knoxville
RECRUITING

Knoxville, Tennessee, 37920, United States
Genesis Clinical Research
RECRUITING

Tampa, Florida, 33603, United States
Global Clinical Professionals (GCP) LLC
RECRUITING

St. Petersburg, Florida, 33705, United States
Orlando Clicinal Research Center
RECRUITING

Orlando, Florida, 32809, United States

Conditions

Explore the condition pages connected to this study.

RENAL IMPAIRMENT